TOP TIERMARKET NEWSWIRE
News & sentiment

ACADIA PHARMACEUTICA (ACAD) — News & AI sentiment

ACADIA PHARMACEUTICA (ACAD) news roundup. 2 stories in the past week, 10 over 30 days. Average 30-day sentiment is 52.7/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $1.0M — net selling of $1.0M. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 1 sale (~$33K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 50/100
30d stories
10
avg sentiment 52.7/100
Insider net (90d)
$1.0M
0 buys · 2 sells
Congress (90d)
-1
0 buys · 1 sells

ACAD news in the last 24 hours, 7 days, 30 days and 90 days

How much ACAD coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowACAD storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days250/100ACAD headlines →
Last 30 days1052.7/100ACAD headlines →
Last 90 days8851.8/100ACAD headlines →

Latest stories on ACAD

5d ago
7d ago
Oct 13
Oct 8
Oct 5
Oct 5
Why is ACADIA Pharmaceuticals stock climbing today?
Investing.com Markets50 · neutralgeneral
Oct 5
Oct 5
Sep 28
Sep 28
Sep 25
Sep 25
Sep 25
Sep 25
Sep 25
Needham cuts Acadia Pharmaceuticals stock price target on trial results
Investing.com Analyst Ratings34 · bearishanalyst
Sep 25
Sep 25
Sep 25
Sep 25
Citizens cuts Acadia Pharmaceuticals stock price target on trial miss
Investing.com Analyst Ratings34 · bearishanalyst
Sep 25
Sep 24
Sep 24
Sep 24
Sep 24
Sep 24
Open ACAD in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →